As of 26 April 2018, Prof. Dr. Ulrich Mittmann and Dr. Roberto Gradnik have officially stepped down as Tillotts Pharma AG (“Tillotts”) board members. The Board has accepted the two members’ decision to step down and thanked them for their years of service and valuable contributions to the success of Tillotts.
Prof. Dr. Ulrich Mittmann, who has been on the board of Tillotts Pharma AG since September 2009, travelled to Japan along with Tillotts CEO Thomas A. Tóth von Kiskér to meet the Chairman of the Board, Mr. Sachiaki Ibe, and officially withdraw from his duties. Chairman Ibe thanked Prof. Mittmann for his many years of dedicated service as a board member by handing over a personal gift. At the same time, Chairman Ibe welcomed Prof. Mittmann’s decision to continue his valuable service as a scientific advisor to the Zeria Group.
Dr. Gradnik was unfortunately not able to travel to Japan on this occasion to take his official goodbye but received a personal letter from Chairman Ibe thanking him for his valuable contribution to Tillotts’ success.
Tillotts would like to thank both Prof. Mittmann and Dr. Gradnik for their valuable contribution and dedicated service over the past years.
Chairman Ibe handed over a personal gift to Prof. Dr. Ulrich Mittmann as a thank you for his dedicated services as a Tillotts Pharma board member. (C) Tillotts Pharma AG